178 related articles for article (PubMed ID: 37330950)
21. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium.
Bauer PS; Gamboa AC; Otegbeye EE; Chapman WC; Rivard S; Regenbogen S; Mohammed M; Holder-Murray J; Wiseman JT; Ejaz A; Edwards-Hollingsworth K; Hawkins AT; Hunt SR; Balch G; Silviera ML
J Surg Oncol; 2024 Feb; 129(2):254-263. PubMed ID: 37792637
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
23. Surgical and short-term oncological safety of total neoadjuvant therapy in high-risk locally advanced rectal cancer.
Ng YY; Seow-En I; Chok AY; Lee TS; Palanisamy P; Tan EK
ANZ J Surg; 2024 Feb; 94(1-2):175-180. PubMed ID: 37849414
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
[TBL] [Abstract][Full Text] [Related]
25. Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
Wu Q; Zhou J; Huang J; Deng X; Li C; Meng W; He Y; Wang Z
Br J Surg; 2023 Jun; 110(7):784-796. PubMed ID: 37191308
[TBL] [Abstract][Full Text] [Related]
26. Short-course versus long-course neoadjuvant radiotherapy for lower rectal cancer: a systematic review.
Sajid MS; Siddiqui MR; Kianifard B; Baig MK
Ir J Med Sci; 2010 Jun; 179(2):165-71. PubMed ID: 19565313
[TBL] [Abstract][Full Text] [Related]
27. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
[TBL] [Abstract][Full Text] [Related]
28. Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials.
Zhang X; Ma S; Guo Y; Luo Y; Li L
PLoS One; 2022; 17(11):e0276599. PubMed ID: 36331947
[TBL] [Abstract][Full Text] [Related]
29. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
Chapman BC; Goodman K; Hosokawa P; Gleisner A; Cowan ML; Birnbaum E; Vogel JD
J Surg Oncol; 2019 Mar; 119(4):518-531. PubMed ID: 30637750
[TBL] [Abstract][Full Text] [Related]
30. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
31. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.
Kong JC; Soucisse M; Michael M; Tie J; Ngan SY; Leong T; McCormick J; Warrier SK; Heriot AG
Ann Surg Oncol; 2021 Nov; 28(12):7476-7486. PubMed ID: 33891203
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract][Full Text] [Related]
33. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
Tan S; Ou Y; Huang S; Gao Q
Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
[TBL] [Abstract][Full Text] [Related]
34. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Hoendervangers S; Burbach JPM; Lacle MM; Koopman M; van Grevenstein WMU; Intven MPW; Verkooijen HM
Ann Surg Oncol; 2020 Oct; 27(11):4319-4336. PubMed ID: 32524461
[TBL] [Abstract][Full Text] [Related]
35. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
36. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.
Liu S; Wang X; Zhuang Y; Bai S; Wu X; Ye Y; Luo H; Yu H; Wang Q; Chang H; Zeng Z; Cai P; Pan Z; Gao Y; Chen G; Xiao W
Cancer Med; 2023 Jun; 12(12):13352-13360. PubMed ID: 37156624
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A Meta-Anaysis of Randomized Controlled Trials.
Gabbani M; Giorgi C; Napoli G; Tebano U; Perrone MS; Missiroli S; Berretta M; Mandarà M; Zaninelli M; Luca N; Grigolato D; Muraro M; Rinaldi G; Pinton P; Fiorica F
Clin Colorectal Cancer; 2022 Dec; 21(4):297-308. PubMed ID: 36210320
[TBL] [Abstract][Full Text] [Related]
38. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
[TBL] [Abstract][Full Text] [Related]
39. Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer.
Kang MK
World J Gastroenterol; 2023 Feb; 29(6):1011-1025. PubMed ID: 36844136
[TBL] [Abstract][Full Text] [Related]
40. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
